Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dupilumab in Persistent Asthma
NCT02414854Phase 3Completed
- Sponsor
- Sanofi
- Start
- Apr 2015
- Primary completion
- Jul 2017
- Modality
- Monoclonal Antibodies
- Countries
- 22
01
Overview
A Phase 3 trial of dupilumab in asthma, sponsored by Sanofi. Started Apr 2015; status: completed.
02
Drugs
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02414854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02414854.